Clinical trial
The Role of Inhaler Device in the Treatment Persistence With Dual Bronchodilators in Patients With COPD
NCT03979807 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Inhaler Device in the Treatment Persistence With Dual Bronchodilators in Patients With COPD
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 10, 2019
- Completion date
- June 11, 2019
- Enrollment
- 11,296 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.